Bovie Medical Corporation (Bovie) is an energy-based medical device company. The Company is engaged in the design, development and manufacturing of electrosurgical equipment by producing equipment for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies. It operates through three segments: Core, OEM and J-Plasma. It is engaged in developing and marketing a range of electrosurgical products and technologies, as well as related medical products used in doctor's offices, surgery centers and hospitals around the world. It also develops J-Plasma, a helium-based plasma surgical product. The J-Plasma system consists of an electrosurgical generator unit, a handpiece and a supply of helium gas. Its products are marketed through brands, including Bovie, Aaron, DERM, IDS and ICON, and on a private label basis to distributors around the world. It offers its products in electrosurgery, cauteries and other products categories.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Medical Equipment Wholesale
- Sub-Industry: N/A
- Symbol: AMEX:BVX
- CUSIP: N/A
- Web: www.boviemedical.com/
- Market Cap: $95.05 million
- Outstanding Shares: 30,859,000
- 50 Day Moving Avg: $2.49
- 200 Day Moving Avg: $2.52
- 52 Week Range: $1.87 - $5.75
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -77.00
- P/E Growth: -1.87
- Annual Revenue: $37.75 million
- Price / Sales: 2.52
- Book Value: $0.76 per share
- Price / Book: 4.05
- EBIDTA: ($3,600,000.00)
- Net Margins: -13.35%
- Return on Equity: -21.74%
- Return on Assets: -15.98%
- Average Volume: 122,814 shs.
- Beta: -0.06
- Short Ratio: 2.61
Frequently Asked Questions for Bovie Medical (AMEX:BVX)
What is Bovie Medical's stock symbol?
Bovie Medical trades on the AMEX under the ticker symbol "BVX."
How were Bovie Medical's earnings last quarter?
Bovie Medical Co. (AMEX:BVX) released its earnings results on Wednesday, August, 2nd. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of ($0.03) by $0.01. The company earned $9.80 million during the quarter, compared to analyst estimates of $8.60 million. Bovie Medical had a negative return on equity of 21.74% and a negative net margin of 13.35%. View Bovie Medical's Earnings History.
When will Bovie Medical make its next earnings announcement?
Where is Bovie Medical's stock going? Where will Bovie Medical's stock price be in 2017?
1 brokerages have issued twelve-month price targets for Bovie Medical's shares. Their predictions range from $6.00 to $6.00. On average, they anticipate Bovie Medical's stock price to reach $6.00 in the next year. View Analyst Ratings for Bovie Medical.
Who are some of Bovie Medical's key competitors?
Some companies that are related to Bovie Medical include Transenterix (TRXC), Transenterix (TRXC), Kadmon Holdings (KDMN), Asterias Biotherapeutics (AST), Asterias Biotherapeutics (AST), Synthetic Biologics (SYN), Sinclair Pharma PLC (SPH), Verona Pharma Plc (VRP), Synthetic Biologics (SYN), Silence Therapeutics plc (SLN), Arch Therapeutics (ARTH), Summit Therapeutics PLC (SUMM), Matinas BioPharma Holdings (MTNB), Nobilis Health Corp (HLTH), MaxCyte (MXCT), Ekf Diagnostics Holding PLC (EKF), Immunodiagnostic Systems Holdings PLC (IDH) and Palatin Technologies (PTN).
Who are Bovie Medical's key executives?
Bovie Medical's management team includes the folowing people:
- Andrew Makrides Esq., Executive Chairman of the Board
- John Robert Saron, President, Chief Sales and Marketing Officer, Director
- Robert L. Gershon, Chief Executive Officer, Director
- Charles Thomas Orsatti, Vice Chairman of the Board
- Jay D. Ewers, Chief Financial Officer, Treasurer, Secretary
- Moshe Citronowicz, Senior Vice President
- John J. McCarthy, Chief Commercialization Officer
- John C. Andres, Independent Director
- Scott R. Davidson, Independent Director
- Michael E. Geraghty, Independent Director
Who owns Bovie Medical stock?
Bovie Medical's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (2.74%), Perkins Capital Management Inc. (1.94%), Emerald Mutual Fund Advisers Trust (1.59%), Cowen Prime Services LLC (0.81%), Dimensional Fund Advisors LP (0.62%) and Raymond James Financial Services Advisors Inc. (0.26%). Company insiders that own Bovie Medical stock include John J Mccarthy III, Moshe Citronowicz and Robert Gershon. View Institutional Ownership Trends for Bovie Medical.
Who sold Bovie Medical stock? Who is selling Bovie Medical stock?
Bovie Medical's stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Perkins Capital Management Inc. and Emerald Mutual Fund Advisers Trust. View Insider Buying and Selling for Bovie Medical.
Who bought Bovie Medical stock? Who is buying Bovie Medical stock?
Bovie Medical's stock was bought by a variety of institutional investors in the last quarter, including Cowen Prime Services LLC, Raymond James Financial Services Advisors Inc., Virtu KCG Holdings LLC, Northern Trust Corp and Vanguard Group Inc.. Company insiders that have bought Bovie Medical stock in the last two years include John J Mccarthy III, Moshe Citronowicz and Robert Gershon. View Insider Buying and Selling for Bovie Medical.
How do I buy Bovie Medical stock?
Shares of Bovie Medical can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Bovie Medical's stock price today?
MarketBeat Community Rating for Bovie Medical (AMEX BVX)MarketBeat's community ratings are surveys of what our community members think about Bovie Medical and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Bovie Medical stock can currently be purchased for approximately $3.08.
Consensus Ratings for Bovie Medical (AMEX:BVX) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||1 Buy Rating|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||$6.00|
Analysts' Ratings History for Bovie Medical (AMEX:BVX)
(Data available from 9/21/2015 forward)
|11/21/2016||Piper Jaffray Companies||Initiated Coverage||Overweight||$6.00|
|8/3/2016||JMP Securities||Reiterated Rating||Outperform||$5.00|
Earnings History for Bovie Medical (AMEX:BVX)Earnings History by Quarter for Bovie Medical (AMEX BVX)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/2/2017||Q2 2017||($0.03)||($0.04)||$8.60 million||$9.80 million||View||Listen|
|5/15/2017||Q1 2017||($0.05)||($0.06)||$8.39 million||View||N/A|
|3/9/2017||Q4 2016||($0.01)||($0.04)||$9.90 million||$9.49 million||View||Listen|
|10/26/2016||Q216||($0.03)||($0.01)||$9.25 million||$10.10 million||View||Listen|
|8/1/2016||Q2 2016||($0.06)||($0.02)||$8.55 million||$9.30 million||View||N/A|
|5/11/2016||Q116||($0.05)||($0.07)||$7.17 million||$7.80 million||View||Listen|
|3/17/2016||Q415||($0.06)||($0.05)||$8.69 million||$8.30 million||View||Listen|
|11/4/2015||Q315||($0.06)||($0.07)||$7.40 million||$7.80 million||View||N/A|
|8/6/2015||Q215||($0.09)||($0.06)||$7.27 million||$7.27 million||View||N/A|
|5/8/2015||Q1 2015||($0.13)||($0.14)||$6.92 million||$6.13 million||View||N/A|
|8/5/2014||Q2 2014||($0.02)||($0.03)||$6.95 million||View||N/A|
|5/15/2014||Q1 2014||($0.05)||($0.01)||$6.48 million||View||N/A|
|11/14/2013||Q3||($0.02)||$6.70 million||$5.80 million||View||N/A|
|8/14/2013||Q2 2013||($0.06)||$7.44 million||$6.04 million||View||N/A|
|5/15/2013||Q1 2013||($0.02)||$6.73 million||$5.70 million||View||N/A|
|4/1/2013||Q4 2012||($0.05)||$6.10 million||$6.83 million||View||N/A|
Earnings Estimates for Bovie Medical (AMEX:BVX)
Current Year EPS Consensus Estimate: $-0.11 EPS
Next Year EPS Consensus Estimate: $-0.04 EPS
Dividend History for Bovie Medical (AMEX:BVX)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Bovie Medical (AMEX:BVX)Insider Trades by Quarter for Bovie Medical (AMEX:BVX)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|8/17/2016||John J Mccarthy III||Insider||Buy||90,750||$3.30||$299,475.00|| |
|12/22/2015||John J Mccarthy III||Insider||Buy||25,000||$1.98||$49,500.00|| |
|12/21/2015||Moshe Citronowicz||VP||Buy||20,000||$1.84||$36,800.00|| |
|12/21/2015||Robert Gershon||CEO||Buy||10,000||$1.82||$18,200.00|| |
|8/14/2015||Robert Gershon||CEO||Buy||20,000||$2.39||$47,800.00|| |
Headline Trends for Bovie Medical (AMEX:BVX)
Latest Headlines for Bovie Medical (AMEX:BVX)
|Bovie Medical Co. (BVX) Downgraded by Zacks Investment Research to Sell|
www.americanbankingnews.com - August 17 at 4:54 PM
|Bovie Medical Co. (AMEX:BVX) Issues Quarterly Earnings Results|
www.americanbankingnews.com - August 3 at 3:38 PM
|Bovie reports 2Q loss|
finance.yahoo.com - August 2 at 10:34 PM
|Bovie Medical Co. (AMEX:BVX) to Release Quarterly Earnings on Wednesday|
www.americanbankingnews.com - July 26 at 7:32 AM
|Bovie Medical Co. (AMEX:BVX) Rating Increased to Hold at Zacks Investment Research|
www.americanbankingnews.com - July 18 at 6:42 PM
|ETFs with exposure to Bovie Medical Corp. : July 10, 2017|
finance.yahoo.com - July 10 at 4:47 PM
|Bovie Medical Corporation to Release Second Quarter 2017 Financial Results on August 2, 2017|
finance.yahoo.com - July 10 at 4:47 PM
|ETFs with exposure to Bovie Medical Corp. : June 29, 2017|
finance.yahoo.com - June 29 at 6:00 PM
|ETFs with exposure to Bovie Medical Corp. : June 16, 2017|
finance.yahoo.com - June 16 at 4:48 PM
|Bovie Medical Corp. :BVX-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017|
finance.yahoo.com - June 14 at 4:49 PM
|Bovie Medical Corporation to Present at the JMP Securities Life Sciences Conference|
finance.yahoo.com - May 31 at 10:25 AM
|Bovie Medical Co. (BVX) Releases Earnings Results, Misses Estimates By $0.01 EPS|
www.americanbankingnews.com - May 16 at 1:10 PM
|Bovie Medical Corporation Reports First Quarter 2017 Financial Results and Introduces Fiscal Year 2017 Financial Outlook|
finance.yahoo.com - May 16 at 9:29 AM
|Bovie reports 1Q loss|
finance.yahoo.com - May 16 at 9:29 AM
|Investor Network Invites You to the Bovie Medical Corporation First Quarter 2017 Earnings Conference Call and Webcast Live on Monday, May 15, 2017|
finance.yahoo.com - May 15 at 10:58 AM
|Bovie Medical Co. (BVX) Downgraded by Zacks Investment Research|
www.americanbankingnews.com - May 11 at 10:16 PM
|Bovie Medical Receives 510K Clearance for its J-Plasma® Precise Flex Handpiece|
finance.yahoo.com - May 8 at 10:17 AM
|Bovie Medical (BVX) Getting Favorable Media Coverage, Study Shows|
www.americanbankingnews.com - April 27 at 8:08 PM
|Bovie Medical Corporation to Release First Quarter 2017 Financial Results on May 15, 2017|
finance.yahoo.com - April 26 at 8:20 PM
|Bovie Medical Receives 510K Clearance for Its Cool-Coag™ Generator and Open Handpiece - Business Wire (press release)|
www.businesswire.com - March 29 at 12:33 PM
|Zacks Investment Research Lowers Bovie Medical Co. (BVX) to Hold|
www.americanbankingnews.com - March 28 at 4:57 PM
|Bovie Medical Receives 510K Clearance for Its Cool-Coag™ Generator and Open Handpiece|
us.rd.yahoo.com - March 27 at 12:45 PM
|Bovie Medical Receives 510K Clearance for Its Cool-Coag™ Generator and Open Handpiece - Yahoo Finance|
finance.yahoo.com - March 27 at 12:45 PM
|PetMed Express' New Order Sales Disappoint, Competition Rife|
finance.yahoo.com - March 24 at 4:24 PM
|Bovie Medical Corporation to Present at 29th Annual Roth Conference|
finance.yahoo.com - March 8 at 4:47 PM
|Investor Network Invites You to the Bovie Medical Corporation Fourth Quarter 2016 Earnings Conference Call and Webcast Live on Thursday, March 9, 2017|
finance.yahoo.com - March 8 at 4:47 PM
|BOVIE MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Other Events|
biz.yahoo.com - December 22 at 9:13 PM
|CVS Health Introduces Transform Diabetes Care Program|
us.rd.yahoo.com - December 16 at 4:24 PM
|AngioDynamics (ANGO) Announces 2.5M Secondary Offering|
finance.yahoo.com - November 16 at 11:35 AM
|BOVIE MEDICAL CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financia|
biz.yahoo.com - November 14 at 6:53 AM
|Bovie Medical Corporation (BVX) Subsides on Stock Offerings|
www.baystreet.ca - November 12 at 11:11 AM
|Bovie Medical Prices Public Offerings Of Common Stock|
www.thestreet.com - November 10 at 12:27 PM
|VWR Corporation (VWR) Tops Earnings, Lags Revenue in Q3|
finance.yahoo.com - November 7 at 10:55 AM
|Bovie Medical Reports 2016 Third Quarter and Nine Month Results|
finance.yahoo.com - October 27 at 8:32 AM
|Bovie Medical Corporation's (BVX) CEO Rob Gershon on Q3 2016 Results - Earnings Call Transcript|
seekingalpha.com - October 27 at 8:32 AM
|Bovie J-Plasma® Precise 360™ Handpiece Named ‘Innovation of the Year’ by the Society of Laparoendoscopic Surgeons (SLS)|
finance.yahoo.com - August 30 at 11:49 AM
|Can Bovie Medical (BVX) Run Higher on Strong Earnings Estimate Revisions?|
finance.yahoo.com - August 30 at 11:49 AM
|Bovie Medical Receives FDA 510(k) Clearance For Its 'PlazXact™' Ablator|
www.thestreet.com - August 18 at 9:28 PM
|Bovie Medical (BVX) Shares March Higher, Can It Continue?|
finance.yahoo.com - August 18 at 12:25 PM
|Bovie Medical Receives FDA 510(k) Clearance for Its ‘PlazXact™’ Ablator|
finance.yahoo.com - August 16 at 11:18 AM
|Bovie Medical (BVX) in Focus: Stock Jumps 10% in Session|
finance.yahoo.com - August 8 at 8:51 AM
|JMP Securities Reviews Bovie Medical's Q2 Results|
www.benzinga.com - August 2 at 9:40 PM
|Bovie Medical's (BVX) CEO Robert Gershon on Q2 2016 Results - Earnings Call Transcript|
seekingalpha.com - August 2 at 8:48 AM
|Bovie Medical Announces Sales Channel Partnership Agreement with Hologic for J-Plasma®|
finance.yahoo.com - July 21 at 8:00 AM
|5:12 pm Bovie Medical enters into a sales channel partnership Agreement with Arteriocyte Medical Systems to sell J-Plasma to its network of plastic surgeons|
finance.yahoo.com - June 30 at 5:12 PM
|Bovie Medical Announces J-Plasma® Sales Channel Partnership with Arteriocyte Medical Systems|
finance.yahoo.com - June 30 at 5:10 PM
|Bovie Medical Corporation Reports First Quarter 2016 Results|
finance.yahoo.com - May 11 at 7:00 AM
|Investor Calendar Invites You to the Bovie Medical Corporation First Quarter 2016 Earnings Conference Call and Webcast Live on Wednesday, May 11, 2016|
finance.yahoo.com - May 10 at 4:05 PM
|Bovie Medical Corporation Announces Time Change for First Quarter 2016 Earnings Call|
finance.yahoo.com - May 9 at 8:00 AM
|Bovie Medical Corporation Announces First Quarter 2016 Earnings Call|
finance.yahoo.com - April 27 at 8:00 AM